Viewing Study NCT04583592


Ignite Creation Date: 2025-12-24 @ 3:16 PM
Ignite Modification Date: 2026-03-03 @ 6:05 PM
Study NCT ID: NCT04583592
Status: COMPLETED
Last Update Posted: 2022-01-18
First Post: 2020-10-07
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Camostat Efficacy vs. Placebo for Outpatient Treatment of COVID-19 (CAMELOT)
Sponsor: Sagent Pharmaceuticals Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-11-09
Start Date Type: ACTUAL
Primary Completion Date: 2021-03-31
Primary Completion Date Type: ACTUAL
Completion Date: 2021-03-31
Completion Date Type: ACTUAL
First Submit Date: 2020-10-07
First Submit QC Date: None
Study First Post Date: 2020-10-12
Study First Post Date Type: ACTUAL
Results First Submit Date: 2021-12-14
Results First Submit QC Date: None
Results First Post Date: 2022-01-18
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-01-13
Last Update Post Date: 2022-01-18
Last Update Post Date Type: ACTUAL